These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6861882)

  • 1. Selective DA2 versus DA1 antagonist activity of domperidone in the periphery.
    Kohli JD; Glock D; Goldberg LI
    Eur J Pharmacol; 1983 Apr; 89(1-2):137-41. PubMed ID: 6861882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel orally active dopamine (DA) prodrug TA-870. IV. Renal vasodilatory and negative chronotropic effects in anesthetized dogs: influence of DA1 and DA2 dopamine receptor selective antagonists.
    Nishiyama S; Yoshikawa M; Yamaguchi I
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):560-7. PubMed ID: 1711621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the enantiomers of 3-PPP on DA1 and DA2 dopamine receptors in the dog.
    Kohli JD; Glock D; Goldberg LI
    Eur J Pharmacol; 1985 Aug; 114(3):305-10. PubMed ID: 4065203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of renal effects of dopamine in the dog by the DA1 antagonist SCH 23390.
    Frederickson ED; Bradley T; Goldberg LI
    Am J Physiol; 1985 Aug; 249(2 Pt 2):F236-40. PubMed ID: 3161340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390.
    Goldberg LI; Glock D; Kohli JD; Barnett A
    Hypertension; 1984; 6(2 Pt 2):I25-30. PubMed ID: 6144634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature.
    Horn PT; Kohli JD
    Eur J Pharmacol; 1991 May; 197(2-3):125-30. PubMed ID: 1680707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bulbocapnine is not a selective DA1 receptor antagonist.
    Kohli JD; Glock D; Goldberg LI
    J Pharm Pharmacol; 1986 May; 38(5):401-2. PubMed ID: 2872323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of tetrahydroberberine on peripheral vascular dopamine DA1 and DA2 receptor subtypes].
    Zhang WF; Zhi JM; Guo W; Zhao RR; Jin GZ
    Zhongguo Zhong Yao Za Zhi; 2000 Aug; 25(8):497-500. PubMed ID: 12515216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral vascular and neuronal effects of dopamine receptor agonists. A comparison with receptor binding studies in rat striatum.
    Semeraro C; Ferrini R; Allievi L; Pocchiari F; Nicosia S; Casagrande C
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):539-46. PubMed ID: 1982561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor blockade does not affect the natriuresis accompanying sodium chloride infusion in dogs.
    Bradley T; Gewertz BL; Scott WJ; Goldberg LI
    J Lab Clin Med; 1986 Jun; 107(6):525-8. PubMed ID: 2940307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral dopamine receptors.
    Kohli JD
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):25S-28S. PubMed ID: 2143385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptors in the stellate ganglion of the dog.
    Kohli JD; Metra M; Satoh Y; Goldberg LI
    Eur J Pharmacol; 1989 May; 164(2):265-72. PubMed ID: 2569409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of l-stepholidine on the peripheral vascular dopamine DA1 and DA2 receptor subtypes].
    Zhang W; Zhi J; Guo W; Zhao R; Jin G
    Yao Xue Xue Bao; 1998 Oct; 33(10):721-6. PubMed ID: 12016922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
    Ensinger H; Majewski H; Hedler L; Starke K
    J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.
    Kopia GA; Valocik RE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):215-21. PubMed ID: 2563287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of cardiovascular actions of 2-amino-5,6-dihydroxytetralin by N,N-di-n-propyl substitution.
    Kohli JD; Goldberg LI; McDermed JD
    Eur J Pharmacol; 1982 Jul; 81(2):293-9. PubMed ID: 6126371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DA1 receptor mediates dopamine-induced relaxation of opossum lower esophageal sphincter in vitro.
    Lombardi DM; Grous M; Fine CF; Barone FC; Fowler PJ; Phyall WB; Rush JA; Ormsbee HS
    Gastroenterology; 1986 Sep; 91(3):533-9. PubMed ID: 2874097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
    Itoh H; Kohli JD; Rajfer SI; Goldberg LI
    J Pharmacol Exp Ther; 1985 Apr; 233(1):87-93. PubMed ID: 2858584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic effects of dopexamine hydrochloride in the canine kidney.
    Bass AS
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):33-6. PubMed ID: 1347154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular effects of selective dopamine receptor agonists and antagonists in the rat kidney.
    Schmidt M; Krieger JP; Giesen-Crouse EM; Imbs JL
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):195-205. PubMed ID: 2954515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.